Clinical trials are constantly subject to innovations that can improve efficiency and overall cost-effectiveness.
The impact and importance of clinical trials was recently highlighted by BBC, citing clinical trials as one of the most important factors in the fight against pancreatic cancer and other illnesses.
Two recent developments that could result in industry-wide changes are improvements in the medical uses of software and the rise of the “digital patient”.
Clinical trials have often previously relied upon patients who can participate in trials on-site. This can often include lengthy and expensive travel times and effort on the part of the patient, who may be inconvenienced by ill health. The development of the “digital patient” now means that a large amount of data and participation can be completed remotely online, unaffected by health or distance. A number of clinical trials have also been able to cut costs in the preparation and recruitment stages of the trials by making use of digital media. Many patients are now made aware of clinical trials via social media. They may also be able to test their suitability with online questionnaires, for example, or register their interest online. Researchers are then able to select from digital applications quickly, easily and at very little cost. Any necessary materials or equipment can then be sent to participants, and their results can be recorded digitally. In this way, the patient is referred to as “digital” because their recruitment, participation and even treatment can all be completed off-site and monitored via online systems.
Reducing overall costs and time-consuming processes such as clinical trials and the FDA 510k clearance process is at the forefront of consideration for many companies within the industry. Innovations such as those available from companies like fdathirdpartyreview and the rise of the digital patient have been a significant aspect of this.
The improvements in intuitive and remote software, in particular wireless “cloud” systems, have had significant impact on the clinical trials industry. It is only with improvements in software that developments such as the digital patient can be facilitated. After beginning as mere theory, cloud systems and collaborative data software sharing systems have begun to revolutionise the ways in which clinical trials gather, share and use data. Over time, it is expected to have far-reaching consequences within the industry and beyond.